Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Hazout

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Human Reproduction (Oxford, England)|April 9, 2004
Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantationJan Tesarik, André Hazout, Carmen Mendoza
Reproductive Biomedicine Online|August 22, 2003
Luteinizing hormone affects uterine receptivity independently of ovarian functionJan Tesarik, André Hazout, Carmen Mendoza
Human Reproduction (Oxford, England)|April 30, 2005
Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormoneJan Tesarik, André Hazout, Carmen Mendoza
Journal of Assisted Reproduction and Genetics|February 1, 2006
Pregnancy and delivery after in vitro maturation of naked ICSI-GV oocytes with GH and transfer of a frozen thawed blastocyst: case reportYves J R Menezo, Bernard Nicollet, Jacques Rollet, et al.
Human Reproduction (Oxford, England)|August 24, 2006
Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cyclesJan Tesarik, André Hazout, Raquel Mendoza-Tesarik, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 26, 2012
Culture systems: embryo co-cultureYves J R Ménézo, Edouard Servy, Anna Veiga, et al.
Reproductive Biomedicine Online|February 4, 2006
High-magnification ICSI overcomes paternal effect resistant to conventional ICSIAndré Hazout, Martine Dumont-Hassan, Anne-Marie Junca, et al.
Zygote (Cambridge, England)|October 20, 2011
Advantages of the two-step embryo transfer strategy in human IVF/ICSI cyclesChadi Yazbeck, Nadia Ben Jamaa, André Hazout, et al.
Fertility and Sterility|November 10, 2004
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolAndré Hazout, Philippe Bouchard, David B Seifer, et al.
Reproductive Biomedicine Online|November 26, 2013
Low birth defects by deselecting abnormal spermatozoa before ICSINino Guy Cassuto, André Hazout, Dominique Bouret, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Human Reproduction (Oxford, England)|April 9, 2004
Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantationJan Tesarik, André Hazout, Carmen Mendoza
Reproductive Biomedicine Online|August 22, 2003
Luteinizing hormone affects uterine receptivity independently of ovarian functionJan Tesarik, André Hazout, Carmen Mendoza
Human Reproduction (Oxford, England)|April 30, 2005
Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormoneJan Tesarik, André Hazout, Carmen Mendoza
Journal of Assisted Reproduction and Genetics|February 1, 2006
Pregnancy and delivery after in vitro maturation of naked ICSI-GV oocytes with GH and transfer of a frozen thawed blastocyst: case reportYves J R Menezo, Bernard Nicollet, Jacques Rollet, et al.
Human Reproduction (Oxford, England)|August 24, 2006
Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cyclesJan Tesarik, André Hazout, Raquel Mendoza-Tesarik, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 26, 2012
Culture systems: embryo co-cultureYves J R Ménézo, Edouard Servy, Anna Veiga, et al.
Reproductive Biomedicine Online|February 4, 2006
High-magnification ICSI overcomes paternal effect resistant to conventional ICSIAndré Hazout, Martine Dumont-Hassan, Anne-Marie Junca, et al.
Zygote (Cambridge, England)|October 20, 2011
Advantages of the two-step embryo transfer strategy in human IVF/ICSI cyclesChadi Yazbeck, Nadia Ben Jamaa, André Hazout, et al.
Fertility and Sterility|November 10, 2004
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolAndré Hazout, Philippe Bouchard, David B Seifer, et al.
Reproductive Biomedicine Online|November 26, 2013
Low birth defects by deselecting abnormal spermatozoa before ICSINino Guy Cassuto, André Hazout, Dominique Bouret, et al.
Pageof 2